Date published: 2025-9-8

021-6093-6350

SCBT Portrait Logo
Seach Input

LTBP-2 抑制因子

LTBP-2 inhibitors are a specialized class of compounds designed to target and inhibit the activity of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP-2). LTBP-2 is a member of the LTBP family of proteins that play a critical role in the regulation of transforming growth factor-beta (TGF-β) signaling, a key pathway involved in cellular growth, differentiation, and extracellular matrix (ECM) formation. Unlike other members of the LTBP family, LTBP-2 does not directly bind to TGF-β but instead interacts with the ECM and other structural components within the cellular environment. Inhibiting LTBP-2 offers researchers a unique tool to study its distinct role in ECM organization, the modulation of cell-matrix interactions, and its broader impact on cell signaling pathways.

The use of LTBP-2 inhibitors in scientific research is particularly valuable for exploring the non-TGF-β related functions of this protein, which are less understood compared to other LTBP family members. By inhibiting LTBP-2, researchers can disrupt its interactions within the ECM, allowing for a closer examination of how these interactions influence tissue architecture, cell adhesion, and mechanical signaling within various cellular contexts. Additionally, LTBP-2 inhibitors help to unravel the complexities of ECM dynamics, shedding light on how alterations in ECM composition and structure can affect cellular behavior and tissue integrity. This class of inhibitors is essential for advancing our understanding of ECM biology, providing insights into the intricate networks that maintain cellular and tissue homeostasis. Through the study of LTBP-2 inhibitors, researchers can gain a deeper appreciation of the multifaceted roles that ECM components play in regulating cell function and the overall maintenance of cellular environments.

関連項目

产品名称CAS #产品编号数量价格应用排名

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
¥903.00
¥2392.00
¥4603.00
48
(1)

可能通过靶向TGF-β通路间接影响潜伏性转化生长因子β结合蛋白(LTBP)。

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
¥1185.00
¥1726.00
4
(1)

另一种TGF-β抑制剂;也可能间接影响潜伏性转化生长因子β结合蛋白(LTBP)。

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
¥1862.00
¥2414.00
¥4468.00
¥6961.00
¥54199.00
19
(1)

另一种MMP抑制剂;也可能间接影响潜伏性转化生长因子β结合蛋白(LTBP)。

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
¥745.00
¥2471.00
¥4705.00
97
(3)

PI3K/Akt/mTOR inhibitor;可能间接调节Latent Transforming Growth Factor Beta Binding Protein (LTBP)。

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
¥1365.00
¥4423.00
148
(1)

另一种PI3K/Akt/mTOR inhibitor;可能间接影响Latent Transforming Growth Factor Beta Binding Protein (LTBP)。

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
¥699.00
¥1749.00
¥3610.00
233
(4)

靶向mTOR,从而间接调节潜在转化生长因子β结合蛋白(LTBP)。

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
¥699.00
¥1264.00
¥2414.00
¥3858.00
74
(2)

另一种EGFR抑制剂;也可能间接影响潜在转化生长因子β结合蛋白(LTBP)。

Halofuginone

55837-20-2sc-507290
100 mg
¥19631.00
(0)

Smad3抑制剂;从而通过Smad依赖性信号传导间接影响潜在转化生长因子β结合蛋白(LTBP)。